Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance : Incidence between 2017 and 2019 and patient profiles from 38.6 million people in six European countries
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:31 |
|---|---|
| Enthalten in: |
Pharmacoepidemiology and drug safety - 31(2022), 5 vom: 30. Mai, Seite 495-510 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Burn, Edward [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 Vaccines |
|---|
| Anmerkungen: |
Date Completed 08.04.2022 Date Revised 16.09.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1002/pds.5419 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM337228701 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM337228701 | ||
| 003 | DE-627 | ||
| 005 | 20231225233934.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/pds.5419 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1124.xml |
| 035 | |a (DE-627)NLM337228701 | ||
| 035 | |a (NLM)35191114 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Burn, Edward |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance |b Incidence between 2017 and 2019 and patient profiles from 38.6 million people in six European countries |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 08.04.2022 | ||
| 500 | |a Date Revised 16.09.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Covid-19 | |
| 650 | 4 | |a post vaccine | |
| 650 | 4 | |a thrombosis-thrombocytopenia syndromes (TTS) | |
| 650 | 4 | |a vaccine | |
| 650 | 7 | |a COVID-19 Vaccines |2 NLM | |
| 700 | 1 | |a Li, Xintong |e verfasserin |4 aut | |
| 700 | 1 | |a Kostka, Kristin |e verfasserin |4 aut | |
| 700 | 1 | |a Stewart, Henry Morgan |e verfasserin |4 aut | |
| 700 | 1 | |a Reich, Christian |e verfasserin |4 aut | |
| 700 | 1 | |a Seager, Sarah |e verfasserin |4 aut | |
| 700 | 1 | |a Duarte-Salles, Talita |e verfasserin |4 aut | |
| 700 | 1 | |a Fernandez-Bertolin, Sergio |e verfasserin |4 aut | |
| 700 | 1 | |a Aragón, María |e verfasserin |4 aut | |
| 700 | 1 | |a Reyes, Carlen |e verfasserin |4 aut | |
| 700 | 1 | |a Martinez-Hernandez, Eugenia |e verfasserin |4 aut | |
| 700 | 1 | |a Marti, Edelmira |e verfasserin |4 aut | |
| 700 | 1 | |a Delmestri, Antonella |e verfasserin |4 aut | |
| 700 | 1 | |a Verhamme, Katia |e verfasserin |4 aut | |
| 700 | 1 | |a Rijnbeek, Peter |e verfasserin |4 aut | |
| 700 | 1 | |a Horban, Scott |e verfasserin |4 aut | |
| 700 | 1 | |a Morales, Daniel R |e verfasserin |4 aut | |
| 700 | 1 | |a Prieto-Alhambra, Daniel |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Pharmacoepidemiology and drug safety |d 1996 |g 31(2022), 5 vom: 30. Mai, Seite 495-510 |w (DE-627)NLM091631106 |x 1099-1557 |7 nnns |
| 773 | 1 | 8 | |g volume:31 |g year:2022 |g number:5 |g day:30 |g month:05 |g pages:495-510 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/pds.5419 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 31 |j 2022 |e 5 |b 30 |c 05 |h 495-510 | ||